Category:

Policy

Govt invites applications for IRDAI chairman post

Subhas Chandra Khuntia, 63 will be completing his three  year term on May 7.

Applicants should have at least 30 years of work experience, should have worked as secretary to Government of India or its equivalent level in Government of India or State Governments or other institutions, and should have had a proven track record of leadership and authority in decision-making.
The applicant should have minimum of two years of residual service as on 7.5.2021, i.e., the applicant’s age should not exceed 63 years on said date.

read more

White House considering intellectual property waiver for COVID-19 vaccines

Critics say waiving the WTO’s agreement on Trade-Related Aspects of Intellectual Property could reduce the safety of vaccines, and that setting up production in new places would sap resources needed to boost production in existing locations.
The United States and several other countries have thus far blocked negotiations at the World Trade Organization (WTO) about a proposal led by India and South Africa that would waive the IP rights of pharmaceutical companies to allow developing countries to produce COVID-19 vaccines.

read more

Can’t be mute spectator in national crisis, don’t intend to supplant HC cases on COVID-19: SC

There is a need for top court’s intervention on certain national issues as there might be matters related to coordination between states, it said.

“We are playing complementary role, if High Courts have any difficulty in dealing with issues due to territorial limitations, we will help,” said the bench, also comprising Justices L Nageswara Rao and S Ravindra Bhat.

read more

Bankers call for more bang to Britain’s big finance fightback

Much is at stake given that Britain’s financial services sector employs 1.1 million people and raises about 75.5 billion pounds a year in tax, a figure which consultants PwC expect to ease in 2021 due to the City of London being effectively cut off from the EU, hitherto its biggest export market.

But many rule changes will need legislation, meaning they may not come into effect until 2022 or beyond.

read more

Govt issues updated clinical guidance for management of Covid-19 patients

Under emergency use authorisation (EUA), remdesivir may be considered for only those patients with moderate to severe diseases (requiring supplemental oxygen) within 10 days of onset of symptoms.

It is not recommended for those with severe renal impairment or hepatic dysfunction, the guidelines stated.

“Not to be used in patients who are not on oxygen support or in home settings,” the ministry underlined.

read more

Covid vaccine-makers largely protected on side effects

While some governments will pay compensation due to sufferers, others assume it is the responsibility of the companies even after drug agencies back the vaccines.
In the US, the Public Readiness and Emergency Preparedness Act authorises the health secretary “to limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines”.

read more